Skip to main content

JANE STREET GROUP, LLC

Position in SLN — Silence Therapeutics plc

CIK 1595888 NEW YORK, NY

Position in SLN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,053,277
+$3,521,393 QoQ
Shares Held
369,151
+265.8% QoQ
Ownership
0.594%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 72 holders
Holding Since
Jun 2025
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SLN Over Time

Shares Held

Position Value (USD)

Derivatives in SLN

reported options exposure · as of Jun 30, 2026
CallValue
$202,032
CallShares
18,400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,364,050,815 across 292 Biotechnology names. SLN ranks #38 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SLN

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $202,032 18,400
2026-06-30 $4,053,277 369,151
2026-03-31 $531,884 100,927
2025-12-31 $177,340 29,168
2025-06-30 $219,314 37,813
2025-06-30 $132,240 22,800